Obesity, therefore, plays a dual role; on the one hand, it promotes the development and progression of cancer through metabolic and immunological disorders, and on the other hand, it may increase the effectiveness of immunotherapies based on PD-1/PD-L1 checkpoint inhibitors [51]. The gene discussed is PDCD1; the disease is Obesity.